Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
12,103 GBX | -0.52% | -2.09% | +14.26% |
May. 16 | AstraZeneca's Sipavibart Prevents COVID-19 in Immunocompromised Patients in Phase 3 Trial | MT |
May. 16 | Global markets live: Cisco, EasyJet, Roche, Netflix, Amazon... |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+14.26% | 239B | |
+32.02% | 694B | |
+29.64% | 593B | |
-1.74% | 371B | |
+19.59% | 331B | |
+6.33% | 290B | |
-3.31% | 209B | |
+9.91% | 209B | |
+8.37% | 169B | |
-0.12% | 164B |
- Stock Market
- Equities
- AZN Stock
- News AstraZeneca PLC
- ASTRAZENECA : JP Morgan maintains a Buy rating